 | | Advancing Gene Therapy to Address Deafness | | | Using gene therapy to treat hereditary deafness is safe and effective in both children and adults, according to new findings from a multicenter clinical trial involving hearing scientist Fan-Gang Zeng, PhD, from the Department of Otolaryngology. Read More | | | |
 | | Eric Vilain, MD, PhD, Appointed Vice Dean for Clinical Research | | | Vilain currently serves as professor of pediatrics, associate vice chancellor for scientific affairs, and director of the Institute for Clinical & Translational Science, and was previously the interim director for the Master of Science in Biomedical and Translational Science (MS-BATS) program. Read More | | | |
|
|